Board of Pharmacy proposes K‑TRACS changes: prison reporting exemption and broader delegate access draw committee concern

The Kansas Board of Pharmacy told the Joint Committee on Administrative Rules and Regulations it will amend K.A.R. 68‑21‑2 to add an exemption from K‑TRACS reporting for pharmacies that dispense controlled drugs to correctional institutions and will adopt a new regulation (K.A.R. 68‑21‑8) to expand who may be a delegate with access to the K‑TRACS prescription drug monitoring system.

Bradford DeYoung explained the reporting exemption would relieve pharmacies that dispense to correctional institutions from routine K‑TRACS reporting for short, institutional supplies, on the board’s view that risk of diversion and doctor‑shopping is very low for those institutional administrations. "The drugs dispensed to a correctional institution are tightly controlled by the correctional institution, and the risk of diversion is incredibly low," DeYoung said. He added the proposed change was requested by pharmacies that found the reporting requirement burdensome.

Several committee members, including Senator Thompson and Representative Sutton, responded with safety and oversight concerns. "I know for a fact there's widespread drug abuse in prison," Senator Thompson said, describing informal barter markets inside correctional facilities and asking whether dispensing records should continue to be tracked externally. DeYoung said K‑TRACS tracks drugs dispensed via legal pharmacy channels up to the point of administration and cannot track illicit redistribution inside institutions; he said reporting by correctional‑institution pharmacies documents the legal supply chain but does not prevent illicit activity after administration.

The proposed K‑TRACS expansion would allow licensed addiction counselors, licensed clinical addiction counselors and licensed master’s addiction counselors to serve as delegates who can access the K‑TRACS database, when authorized by a supervising prescriber. DeYoung said the change responds to requests that counselors assisting with treatment be able to consult prescribing history when treating patients for addiction. Committee members raised multiple privacy and constitutional questions, asking whether counsel had examined restrictions on access, whether the attorney general had opined on constitutional search issues, and whether the board had defined limits that would prevent non‑patients from being queried. "This seems to me a policy decision perhaps for the legislature to be making," Senator Warren said, noting the sensitivity of prescription‑history data.

DeYoung pointed the committee to K.S.A. 65‑16‑82, which authorizes the board to define delegates by rule. He also noted K‑TRACS maintains audit trails and that statute and regulation create penalties for misuse of the system; he agreed to follow up with the committee on the precise statutory and regulatory restrictions that limit delegate access and on the board’s correspondence requesting the change. Several members asked the board to delay final action while those legal and procedural questions are resolved and recommended limiting delegates to counselors who have an active treatment relationship with the patient.

The committee did not vote on the proposed changes. Members requested the board provide: the origin and number of requests to expand delegate access, any attorney‑general or legal review of Fourth Amendment or privacy risks, the precise statutory authority and limiting conditions for delegates, and further documentation on whether correctional‑institution reporting is covered elsewhere by Department of Corrections recordkeeping.